Vijaya Diagnostic Centre Limited has informed the Exchange regarding Grant of 2500 Options.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.7 pts more than Nifty Smallcap 250 and 7.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre's board met on July 28, 2025 and approved three items. First, they approved the unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025), along with limited review reports. Second, they granted 2,500 Employee Stock Options (ESOPs) under the VDCL ESOP Plan 2018 at an exercise price of ₹780 per share — a 20% discount on the three-month average closing price. These options vest over three years (25%, 25%, 50%) and are aimed at employees in support functions like Finance, IT, Strategy, and Operations. Third, they appointed M/s. Balaramakrishna & Associates as the company's Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30, subject to shareholder approval at the upcoming AGM.
The ESOP grant is tiny (only 2,500 shares, negligible dilution) and is a routine employee incentive. The secretarial auditor appointment and quarterly results approval are standard governance actions with no material impact on shareholders or stock price expected.